The National Diabetes Management Strategy: Diabetes Facts and Figures By using these slides, you agree to the terms on the next slide. The development.

Slides:



Advertisements
Similar presentations
The National Diabetes Management Strategy: Diabetes Facts and Figures
Advertisements

The National Diabetes Management Strategy: Diabetes Facts and Figures By using these slides, you agree to the terms on the next slide. The development.
The National Diabetes Management Strategy: Diabetes Facts and Figures By using these slides, you agree to the terms on the next slide. The development.
The National Diabetes Management Strategy: Diabetes Facts and Figures By using these slides, you agree to the terms on the next slide. The development.
World Health and Sustainability
Long Term Care, Family Caregiving and the Law of Succession Part One Josephine Gittler The Aging Population, Alzheimer’s and Other Dementias: Law and Public.
1 Contract Sunshine Act Report Legislative Audit Bureau October 13, 2011.
1 Medical Assistance Program (report 11-15) Legislative Audit Bureau February 2012.
The National Diabetes Management Strategy: Diabetes Facts and Figures By using these slides, you agree to the terms on the next slide. The development.
Government and Health Care Roughly 15 cents of every dollar spent in US is on health care US health care spending equaled $5841 per person in 2002 Governments.
Chronic Disease A Public Health Perspective. Chronic Disease Overview The most prevalent, costly, and preventable chronic diseases –cardiovascular disease.
AAA-PRACTICE COMPLIANCE COMMITTEE PRESENTS: ANTIKICKBACK STATUTE & STARK LAWS AS THEY APPLY TO AUDIOLOGY PRACTICES.
International Diabetes Federation
International Diabetes Federation
Chronic Disease A Public Health Perspective Ronald Fischbach, Ph.D.
ACT on Alzheimer’s Disease Curriculum Module III: Societal Impact.
Strengthening partnerships: A National Voluntary Health Agency’s initiatives in managed care Sarah L. Sampsel, MPH* Lisa M. Carlson, MPH, CHES* Michele.
Developing a Metric Set for Measuring and Reporting Ambulatory Quality of Care in the Setting of Health IT with HIE Lisa M. Kern, MD, MPH Rina V. Dhopeshwarkar,
GPRA Government Performance and Results Act Mary Brickell, IT Specialist, GPRA Coordinator Portland Area Indian Health Service March 2012.
The Global Burden of Diabetes Dr. Naeem Zahid MD, PhD, MBA.
Disclaimer This presentation is intended only for use by Tulane University faculty, staff, and students. No copy or use of this presentation should occur.
The New Brunswick Situation What is the provincial government proposing? 1.
Welcome to Managing the Finances of Your NHPRC Grant 1.
Group 7 Burden of disease in Brazil. KEY HEALTH INDICATORS Years of life lost (YLLs): Years of life lost due to premature mortality. Years lived with.
The National Diabetes Management Strategy: Diabetes Facts and Figures By using these slides, you agree to the terms on the next slide. The development.
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2014 by Standard.
Proportion of biotech-derived active substances in development for first launch 31st December APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Legal Issues. Overview Standard Contract Terms of Social Networking Sites Government Content on a Third-Party Site Competitive Procurement Issues First.
April 17, 2012 Fiscal Director’s Refresher Jane Snead.
Chronic Disease Cost Calculator 1:00 p.m.-2:30 p.m. ET Friday, May 1, 2009 Diane Orenstein, Ph.D. Division for Heart Disease and Stroke Prevention, CDC.
Legal Disclaimers Accuracy Every effort is made to provide information that is accurate. However any information contained in this website or the “article.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage Receipts.
The Costs of Chronic Disease
14 June 2011 Global economic recovery: From a surging start to a softer patch? Rob Dobson.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage Supplier Returns.
Proportion of total R&D expenditure by therapeutic area in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS Your.
Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output MARCH 2008 SOURCE: CMR INTERNATIONAL.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Inspect Material.
2005/2006 Expenditure on biotech derived entities had remained constant APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
Your Local State Health Insurance Assistance Program (SHIP) office: Tom Everett ex. 104 This presentation may.
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
This report is available at: This slide set contains slides from Long-Term Care Providers and Services.
Allocation of R&D expenditure in 2005 between chemical entity and biological or biotech active substances APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Disease Interventions. Activity 17: Disease Interventions LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently.
Report on Jobs – Vacancy Trends 19 July 2012 Markit Economics.
Diabetes in Trinidad and Tobago HEU, Centre for Health Economics November 15 th, 2011.
Chronic Disease A Public Health Perspective. Chronic Disease Overview The most prevalent, costly, and preventable chronic diseases –cardiovascular disease.
Can Newspapers Survive Paul Harris / London / October 2012.
The secure site rendering issue (all navigation crushed together as a list at the top of the page) is a compatibility issue with Internet Explorer only.
The Minnesota State Colleges and Universities system is an Equal Opportunity employer and educator. Presented to the Board of Trustees March 2007 FY
Copyright © 2012, Oracle and/or its affiliates. All rights reserved. Oracle Proprietary and Confidential. 1.
Markit PMI James Kwan \ ***DATE*** The Science of Finance.
Connectivity to bank and sample account structure
Disclaimer This presentation is intended only for use by Tulane University faculty, staff, and students. No copy or use of this presentation should occur.
The Economic, Emotional and Physical Costs of Diabetes: Facts & Figures Felicia Hill-Briggs, PhD, ABPP 2018 President of Health Care and Education, American.
Texas Health Care Network - Employer Presentation
Amphitheater Public Schools
Speaker: Sarah Chambers, Esq. Claims Counsel| Professional Liability
2006 Revenue continued to depend on a relatively small number of products APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
, R&D expenditure showed 6% growth annually
2002–2006 Mid and Other sized companies continued to launch the majority of NMEs APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON.
The Future Use of Technology in Outpatient Care Using the Computerized Patient Record to Implement Principles of Disease Management: Focus on the.
Healthcare Policies in GCC: Challenges and Future Directions:
Development time for new molecular entities first launched onto the world market between MARCH 2008 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS.
Proportion of total R&D expenditure by function in 2005
Diabetes econonomy2 Amini Masoud 1397.
Heart Failure Currently, an estimated 5.7 million Americans are living with heart failure. An additional 670,000 new cases are diagnosed annually, up.
Cancer Costs Projected to Reach at Least $158 Billion in 2020
Age-standardized* prevalence and number of cases of diagnosed diabetes among individuals aged 1 year and older, Canada, 1998/99 to 2008/09. *Age-standardized.
Presentation transcript:

The National Diabetes Management Strategy: Diabetes Facts and Figures By using these slides, you agree to the terms on the next slide. The development of these slides was made possible through financial support by Merck.

Terms of Use By using this web site and/or these slides and/or requesting and receiving the information on this site, you are accepting these terms of use. These slides and the related information on the The National Diabetes Management Strategy website synthesize publicly available information in a convenient format. This information is intended for use by policymakers, managers, media, planners, clinicians and researchers. All information provided on this site and in these slides is publicly available from the original sources. All information is attributed to the original source. All information in these slides is copyrighted by other parties. As a visitor to this site, you are granted a limited license to use the information contained within for non-commercial use only, provided the information is not modified and all copyright and other proprietary notices are retained. The National Diabetes Management Strategy and The University of Western Ontario resides in Ontario, Canada and this site and any transactions which you enter into through this site are governed by the laws of Ontario, Canada and the federal laws of Canada applicable therein. The faculty and staff of The National Diabetes Management Strategy The University of Western Ontario shall not be liable for any damages, claims, liabilities, costs or obligations arising from the use or misuse of the material contained on this web site, whether such obligations arise in contract, negligence, equity or statute law. The National Diabetes Management Strategy and The University of Western Ontario do not guarantee or warrant the quality, accuracy, completeness, timeliness, appropriateness or suitability of the information provided. Links to other sites are provided as a reference to assist you in identifying and locating other Internet resources that may be of interest. The National Diabetes Management Strategy and The University of Western Ontario does not assume responsibility for the accuracy or appropriateness of the information contained on other sites, nor do we endorse the viewpoints expressed on other sites.

Diabetes is an Expensive Disease

Diabetes is Straining Worldwide Healthcare Budgets In 2012, the estimated global healthcare cost to diagnose and treat diabetes is at least $471 billion USD. International Diabetes Federation. Diabetes Atlas Update 2012.

Diabetes is Straining Canadian Healthcare Budgets The economic burden of diabetes in Canada is: –currently estimated to be $12.2. billion –expected to increase to $16.9 billion by The direct costs of diabetes currently account for approximately 3.5% of public healthcare spending. Canadian Diabetes Association. An Economic Tsunami, The Cost Of Diabetes. 2009

Healthcare Costs for Diabetes Will Increase As the general population ages, the prevalence of diabetes and the associated costs are expected to increase. As the population with diabetes ages, there will be an increase in long-term complications (e.g. cardiovascular disease, kidney disease) and associated costs to treat these complications (e.g. hospitalizations, dialysis). Public Health Agency of Canada. Diabetes in Canada: Facts and Figures from a Public Health Perspective. Ottawa, ON: 2011.

Diabetes is Straining American Healthcare Budgets In 2012, the total estimated cost of diagnosed diabetes was $245 billion – $176 billion in direct medical costs and $69 billion in reduced productivity. People with diagnosed diabetes have medical expenditures that are about 2.3 times higher than they would be in the absence of diabetes. More than 1 in 5 healthcare dollars in the US is spent on people with diabetes. American Diabetes Association. Economic costs of diabetes in the U.S. in Diabetes Care. Ahead of print, March 6, 2013.